Miroculus is developing a single, affordable and non-invasive test with microRNA for cancer detection before B3:G41 appear.

Miroculus brings an accurate, easy to use, non-invasive, decentralized, operator independent and affordable microRNA detection platform for molecular data gathering, analysis and interpretation.

We are building a near future where diseases are treated better, because they are constantly diagnosed and monitored at the molecular level.

>
00

Employees

1990

Founded

>10000

Invested

Cm dashboard